BioELife Statistics

Total Valuation

BioELife has a market cap or net worth of 9.

Market Cap	9
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

BioELife has 9.41 million shares outstanding.

Shares Outstanding	9.41M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+78.22%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.00
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.54

Current Ratio	0.54
Quick Ratio	0.54
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.14

Financial Efficiency

Return on equity (ROE) is -598.11% and return on invested capital (ROIC) is -24.00%.

Return on Equity (ROE)	-598.11%
Return on Assets (ROA)	-16.48%
Return on Capital (ROIC)	-24.00%
Revenue Per Employee	n/a
Profits Per Employee	-589,687
Employee Count	1
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.75% in the last 52 weeks. The beta is 1.44, so BioELife's price volatility has been higher than the market average.

Beta (5Y)	1.44
52-Week Price Change	-99.75%
50-Day Moving Average	0.00
200-Day Moving Average	0.00
Relative Strength Index (RSI)	26.54
Average Volume (20 Days)	1,924

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.60

Income Statement

Revenue	n/a
Gross Profit	-800
Operating Income	-90,993
Pretax Income	-589,687
Net Income	-589,687
EBITDA	n/a
EBIT	-90,993
Earnings Per Share (EPS)	-0.17

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	22,247
Total Debt	n/a
Net Cash	22,247
Net Cash Per Share	0.00
Equity (Book Value)	6,927
Book Value Per Share	0.00
Working Capital	-18,707

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -116,037 and capital expenditures -12,064, giving a free cash flow of -128,101.

Operating Cash Flow	-116,037
Capital Expenditures	-12,064
Free Cash Flow	-128,101
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioELife does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-33.70%
Shareholder Yield	-33.70%
Earnings Yield	-17,133,500.00%
FCF Yield	-1,361,332.71%

Stock Splits

The last stock split was on December 4, 2018. It was a reverse split with a ratio of 0.025.

Last Split Date	Dec 4, 2018
Split Type	Reverse
Split Ratio	0.025

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a